市场调查报告书
商品编码
1236070
冷链包装全球市场规模研究与预测,按产品类型(EPS 容器、PUR 容器、托盘托运人、真空隔热板等),按应用(製药、食品、工业),区域分析,2022-2029 年Global Cold Chain Packaging Market Size study & Forecast, by Product Type (EPS Containers, PUR Containers, Pallet Shippers, Vacuum Insulated Panels, Others), by Application (Pharmaceuticals, Food, Industrial) and Regional Analysis, 2022-2029 |
2021 年全球冷链包装市场价值约为 208.9 亿美元,预计在 2022-2029 年预测期内将以超过 10.9% 的健康增长率增长。
冷链包装是涉及货物包装和运输的各种系统,需要将其保持在特定温度下以保持和保持质量和功效。 这种包装有助于将药品、食品和工业产品等商品保持在合适的温度下。 对有效包装解决方案的需求不断增长,新兴国家的快速城市化以及对加工即食食品的需求不断增加是推动全球市场需求的主要因素。。
冷链包装市场的扩张在很大程度上是由製药行业推动的,因为对温度敏感的货物的运输需求不断增长。 药品包装由真空绝缘板、盒子、容器、托盘托运人和板条箱组成,用于储存免疫、输液和注射剂、生物製剂、激素、胰岛素、抗生素、细胞治疗药物、试剂和其他治疗药物。 因此,对特殊热包装和运输系统以保持产品质量的需求不断增加。 根据 IQVIA 的 Pharmaceutical Commerce Analysis,2018 年约有 18% 的药品预算用于冷链,包括消耗品和运输。 在製药业务中,冷链解决方案的增长速度是非冷链解决方案的两倍。 此外,据报导,生物製药产品的销售额已从 2019 年的 2660 亿美元增至 2020 年的 2840 亿美元。 因此,这些高价值药品通常在冷链的帮助下分布在全球分销网络中,从而以显着的速度推动市场增长。 此外,增加对先进技术开发的投资和对可持续包装的日益关注在预测期内提供了各种有利可图的机会。 然而,所需的高初始成本和復杂监管框架的存在正在影响整个 2022-2029 年预测期内的市场增长。
冷链包装全球市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于对新鲜和有机食品消费的日益偏好以及许多市场进入者的存在,北美在销售方面占据了市场主导地位。 另一方面,由于技术发展的进步和对药品的需求不断增长等因素,预计亚太地区在预测期内将以最高的复合年增长率增长。
本研究的目的是弄清近年来各个领域和国家的市场规模,并对未来几年的市场规模进行预测。 该报告旨在捕捉被调查国家工业的定性和定量方面的情况。
它还提供了关键方面的详细信息,例如决定市场未来增长的驱动因素和挑战。 此外,它还结合了利益相关者投资的潜在微观市场机会,以及主要参与者的竞争格局等详细分析。
Global Cold Chain Packaging Market is valued at approximately USD 20.89 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.9% over the forecast period 2022-2029. Cold chain packaging is a variety of systems that includes packaging and shipping of goods that need to be stored at a specific temperature to preserve and maintain their quality and effectiveness. This packaging helps in storing goods such as pharmaceuticals, food, and industrial at a suitable temperature. The surging demand for effective packaging solutions, rapid urbanization in emerging economies, coupled with the increasing demand for processed and easy-to-eat food items are the key factors that are fostering market demand across the world.
The expansion of the cold chain packaging market is primarily influenced by the pharmaceutical industry owing to the rising need for transporting temperature-sensitive goods. The pharmaceutical packaging comprises vacuum-insulated panels, boxes, containers, pallet shippers, and crates, which are used to store vaccinations, infusions/injections, biologics, hormones, insulin, antibiotics, cellular therapies, reagents, and other treatment alternatives. Accordingly, a growing requirement for specialized thermal packing and transportation systems to maintain product quality. According to the Pharmaceutical Commerce Analysis of IQVIA, in 2018, approximately 18% of the total pharma budget is spent on the cold chain, which includes supplies and transportation. In the pharmaceutical business, the growth of cold chain solutions is increasing 2 times faster than that of non-cold chain solutions. Moreover, also reported that the sales of biotechnology drugs products rose to USD 284 billion in 2020 from USD 266 billion in 2019. Consequently, these high-value medicinal items are typically distributed throughout the whole global distribution network with the help of the cold chain, which, in turn, augments the market growth at a substantial rate. Moreover, rising investment in the development of advanced technology, as well as the growing focus on sustainable packaging are presenting various lucrative opportunities over the forecasting years. However, the high initial costs required and the presence of a complex regulatory framework are challenging the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Cold Chain Packaging Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising preference towards the intake of fresh and organic food, along with the high presence of a large number of major industry participants. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising technological developments and high demand for medicines in the market space.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable